New Hope for People Living with a Disease Once Deemed Untreatable: Belite Bio Announces Positive Topline Results from the Pivotal Global, Phase 3 DRAGON Trial …

Tinlarebant is the first therapeutic candidate to demonstrate clinical efficacy in a global Phase 3 trial for Stargardt ...
Open Heart

Development and validation of a 10-year predictive model for cardiovascular and metabolic disease risk: insights from a large-scale health examination cohort

Objective To develop and validate a 10-year predictive model for cardiovascular and metabolic disease (CVMD) risk using ...

Medical Membranes Market worth $6.66 billion by 2030 - Exclusive Report by MarketsandMarkets™

Process Technology (Ultrafiltration, Microfiltration, Nanofiltration), Application (Pharmaceutical Filtration, Hemodialysis, ...